Matthew Kurian, Executive Committee Member at KYSCO, shared on LinkedIn:
“Excited to be attending my first ESMO – European Society for Medical Oncology this year in Madrid!
Here are my Top 5 breast cancer abstracts I’ll be watching at ESMO2026!
Breast cancer is moving incredibly fast with 10 new FDA indications already since May 2026, with more potentially practice changing data to come in Madrid!
Plenty to discuss. I will continue to post about other abstracts over the next few weeks I am interested in as well!
Looking forward to the science and seeing many friends and colleagues soon! DM if you’d like to meet!”
Other articles about ESMO on OncoDaily.